These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 19758360

  • 21. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP, Schimke E.
    Med Klin (Munich); 1995 Oct 15; 90(10):557-61. PubMed ID: 7500918
    [Abstract] [Full Text] [Related]

  • 22. Comparing hormonal and symptomatic responses to experimental hypoglycaemia in insulin- and sulphonylurea-treated Type 2 diabetes.
    Choudhary P, Lonnen K, Emery CJ, MacDonald IA, MacLeod KM, Amiel SA, Heller SR.
    Diabet Med; 2009 Jul 15; 26(7):665-72. PubMed ID: 19573114
    [Abstract] [Full Text] [Related]

  • 23. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
    Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, Oster P, Wolf G, Schiel R.
    Patient Educ Couns; 2008 Oct 15; 73(1):50-9. PubMed ID: 18583087
    [Abstract] [Full Text] [Related]

  • 24. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C.
    Diabetes Educ; 2006 Oct 15; 32(6):910-7. PubMed ID: 17102158
    [Abstract] [Full Text] [Related]

  • 25. [Adverse effects of oral hypoglycemic drugs in elderly patients].
    Zakowska-Wachelko B.
    Pol Tyg Lek; 2006 Oct 15; 45(19-20):389-91. PubMed ID: 2255657
    [No Abstract] [Full Text] [Related]

  • 26. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA, Zinman B, Campos RV, Strack T, Canadian Lispro Study Group.
    Clin Invest Med; 2001 Dec 15; 24(6):292-8. PubMed ID: 11767232
    [Abstract] [Full Text] [Related]

  • 27. Tolerability outcomes of a multicenter, observational, open-label, drug-surveillance study in patients with type 2 diabetes mellitus treated with pioglitazone for 2 years.
    Grossman LD, Parlan G, Bailey AL, Yee G, Yu M, Chan JY.
    Clin Ther; 2009 Jan 15; 31(1):74-88. PubMed ID: 19243708
    [Abstract] [Full Text] [Related]

  • 28. Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes.
    Derosa G, Tinelli C, Maffioli P.
    Diabetes Obes Metab; 2009 Dec 15; 11(12):1091-9. PubMed ID: 19765050
    [Abstract] [Full Text] [Related]

  • 29. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel.
    Curr Med Res Opin; 2009 Nov 15; 25(11):2643-54. PubMed ID: 19751116
    [Abstract] [Full Text] [Related]

  • 30. Patient-reported perceptions of side effects of antihyperglycemic medication and adherence to medication regimens in persons with diabetes mellitus.
    Chao J, Nau DP, Aikens JE.
    Clin Ther; 2007 Jan 15; 29(1):177-80. PubMed ID: 17379058
    [Abstract] [Full Text] [Related]

  • 31. Probable hypoglycemic adverse drug reaction associated with prickly pear cactus, glipizide, and metformin in a patient with type 2 diabetes mellitus.
    Sobieraj DM, Freyer CW.
    Ann Pharmacother; 2010 Jan 15; 44(7-8):1334-7. PubMed ID: 20516361
    [Abstract] [Full Text] [Related]

  • 32. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA, Lee LJ, Shi L, Reynolds K, Jackson JA, Fonseca V.
    Diabet Med; 2008 Aug 15; 25(8):924-32. PubMed ID: 18959605
    [Abstract] [Full Text] [Related]

  • 33. Antihyperglycaemic therapy in elderly patients with type 2 diabetes: potential role of incretin mimetics and DPP-4 inhibitors.
    Mathieu C, Bollaerts K.
    Int J Clin Pract Suppl; 2007 Aug 15; (154):29-37. PubMed ID: 17593275
    [Abstract] [Full Text] [Related]

  • 34. Initiating insulin therapy with, or switching existing insulin therapy to, biphasic insulin aspart 30/70 (NovoMix 30) in routine care: safety and effectiveness in patients with type 2 diabetes in the IMPROVE observational study.
    Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Wenying Y, IMPROVE Study Group Expert Panel.
    Int J Clin Pract; 2009 Mar 15; 63(3):522-31. PubMed ID: 19187170
    [Abstract] [Full Text] [Related]

  • 35. Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort.
    Dornhorst A, Lüddeke HJ, Sreenan S, Koenen C, Hansen JB, Tsur A, Landstedt-Hallin L.
    Int J Clin Pract; 2007 Mar 15; 61(3):523-8. PubMed ID: 17313628
    [Abstract] [Full Text] [Related]

  • 36. Diabetes medications and body weight.
    Mitri J, Hamdy O.
    Expert Opin Drug Saf; 2009 Sep 15; 8(5):573-84. PubMed ID: 19538102
    [Abstract] [Full Text] [Related]

  • 37. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y, Guo XH, Vaz JA, PRESENT Study Group.
    Diabetes Obes Metab; 2009 Jan 15; 11(1):33-40. PubMed ID: 18494806
    [Abstract] [Full Text] [Related]

  • 38. Overcoming barriers to insulin replacement.
    Kuritzky L.
    J Fam Pract; 2009 Aug 15; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract] [Full Text] [Related]

  • 39. Fear of hypoglycaemia in adults with Type 1 diabetes.
    Anderbro T, Amsberg S, Adamson U, Bolinder J, Lins PE, Wredling R, Moberg E, Lisspers J, Johansson UB.
    Diabet Med; 2010 Oct 15; 27(10):1151-8. PubMed ID: 20854383
    [Abstract] [Full Text] [Related]

  • 40. Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy.
    Roborel de Climens A, Tunceli K, Arnould B, Germain N, Iglay K, Norquist J, Brodovicz KG.
    Curr Med Res Opin; 2015 Apr 15; 31(4):643-65. PubMed ID: 25708743
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.